CHASE INVESTMENT COUNSEL CORP

Position in GILD — Gilead Sciences, Inc.

CIK 19475 CHARLOTTESVILLE, VA

Position in GILD

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$646,987

-$66,726 QoQ

Shares Held

5,121

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

#1,264

of 2,266 holders

Holding Since

Jun 2021

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CHASE INVESTMENT COUNSEL CORP holds $12,873,117 across 6 Drug Manufacturers - General names. GILD ranks #5 (5.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	30,025	$7,555,491
2	LLY	ELI LILLY & Co	1,660	$1,991,053
3	MRK	Merck & Co., Inc.	9,815	$1,261,227
4	JNJ	Johnson & Johnson	4,714	$1,197,214
5	GILD	Gilead Sciences, Inc. This page	5,121	$646,987
6	BMY	Bristol Myers Squibb Co	3,838	$221,145

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$646,987	5,121	0.0%	Shares	Sole	2026-08-06
2026-03-31	$713,713	5,121	0.0%	Shares	Sole	2026-05-12
2025-12-31	$628,551	5,121	-0.4%	Shares	Sole	2026-02-05
2025-09-30	$570,651	5,141	-50.1%	Shares	Sole	2025-11-10
2025-06-30	$1,141,295	10,294	+29.6%	Shares	Sole	2025-08-05
2025-03-31	$890,237	7,945	0.0%	Shares	Sole	2025-05-12
2024-12-31	$733,879	7,945	+150.1%	Shares	Sole	2025-02-05
2021-12-31	$230,681	3,177	+0.9%	Shares	Sole	2022-02-02
2021-09-30	$219,957	3,149	+2.9%	Shares	Sole	2021-11-04
2021-06-30	$210,711	3,060	—	Shares	Sole	2021-07-29
No filing history on record for this holder in this stock.